NanoSphere Health Sciences Inc.

NSHS

CA63010P2098

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets 17:56:46 21/05/2024 BST			5-day change	1st Jan Change
0.03 ^CAD	+20.00%		0.00%	+200.00%

04-30	NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 31, 2021 at 10:31 pm

NanoSphere Health Sciences Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced net loss was USD 66,631 compared to USD 235,284 a year ago.

Latest news about NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/08/23	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/05/23	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/04/23	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	27/04/23	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/11/22	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/08/22	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	24/05/22	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/04/22	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	24/04/22	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/11/21	CI
NanoSphere Health Sciences Inc. announced that it expects to receive CAD 0.234 million in funding	16/09/21	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/08/21	CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	31/05/21	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	29/04/21	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	29/04/21	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	29/11/20	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	29/08/20	CI
Nanosphere Health Sciences Inc. Announces Earnings Results for the First Quarter Ended March 31, 2020	15/07/20	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	15/06/20	CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt	14/06/20	CI
NanoSphere Health Sciences Inc. Announces Resignation of Mark Percival as CEO	21/04/20	CI
NanoSphere Health Sciences Inc. Provides Update on United States Operations	09/12/19	CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	28/11/19	CI

Chart NanoSphere Health Sciences Inc.

Duration

Period

More charts

Company Profile

NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Companyâs operating division in the United States.

Sector

Pharmaceuticals

Calendar

27/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
NANOSPHERE HEALTH SCIENCES INC.	+200.00%	189K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.35%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+17.81%	15.11B
CIPLA LIMITED	+15.73%	13.61B
ZYDUS LIFESCIENCES LIMITED	+57.91%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.75B
STADA ARZNEIMITTEL	-8.87%	5.73B